Skylands Capital LLC Makes New Investment in Aspen Aerogels, Inc. (NYSE:ASPN)

Skylands Capital LLC purchased a new stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 54,800 shares of the construction company's stock, valued at approximately $350,000. Skylands Capital LLC owned 0.07% of Aspen Aerogels as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also modified their holdings of ASPN. Millennium Management LLC raised its holdings in Aspen Aerogels by 4,757.8% during the fourth quarter. Millennium Management LLC now owns 1,622,022 shares of the construction company's stock worth $19,270,000 after purchasing an additional 1,588,632 shares in the last quarter. Point72 Asset Management L.P. acquired a new position in shares of Aspen Aerogels during the 4th quarter valued at $13,122,000. Alyeska Investment Group L.P. bought a new stake in shares of Aspen Aerogels in the 4th quarter worth $9,504,000. Dendur Capital LP acquired a new stake in shares of Aspen Aerogels in the fourth quarter valued at $9,207,000. Finally, Renaissance Technologies LLC lifted its holdings in shares of Aspen Aerogels by 472.4% in the fourth quarter. Renaissance Technologies LLC now owns 766,400 shares of the construction company's stock valued at $9,105,000 after buying an additional 632,500 shares during the period. 97.64% of the stock is currently owned by institutional investors.

Aspen Aerogels Stock Down 4.2%

ASPN stock opened at $5.89 on Monday. Aspen Aerogels, Inc. has a 52-week low of $4.16 and a 52-week high of $33.15. The company's 50 day simple moving average is $5.85 and its 200-day simple moving average is $8.14. The company has a debt-to-equity ratio of 0.40, a current ratio of 4.22 and a quick ratio of 3.53. The firm has a market capitalization of $483.63 million, a P/E ratio of -1.69 and a beta of 2.69.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The construction company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.01. Aspen Aerogels had a negative net margin of 65.47% and a positive return on equity of 6.69%. The firm had revenue of $78.72 million for the quarter, compared to analysts' expectations of $82.75 million. During the same period in the previous year, the company posted ($0.02) EPS. The company's quarterly revenue was down 16.7% compared to the same quarter last year. As a group, equities research analysts anticipate that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Insider Buying and Selling at Aspen Aerogels

In related news, CEO Donald R. Young bought 20,000 shares of the business's stock in a transaction on Monday, May 12th. The stock was bought at an average price of $5.35 per share, for a total transaction of $107,000.00. Following the transaction, the chief executive officer now directly owns 550,856 shares in the company, valued at $2,947,079.60. This represents a 3.77% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 3.40% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on ASPN. TD Cowen raised Aspen Aerogels to a "strong-buy" rating in a report on Tuesday, March 11th. Barclays reaffirmed an "equal weight" rating and issued a $7.00 price objective (down previously from $13.00) on shares of Aspen Aerogels in a research note on Thursday, May 29th. Finally, Oppenheimer lowered shares of Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 8th. One research analyst has rated the stock with a sell rating, three have given a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $18.44.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.